Factor This Power Engineering
Live Events
DTECH⢠Events
POWERGEN®
Calendar
Resource Center
Webinars
Podcasts
White Papers
Contribute Content
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Project Development
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Resource Center
Webinars
Podcasts
Whitepapers
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by 89bio, Inc.
< Previous
1
2
Next >
89bio, Inc. Announces Agreement to be Acquired by Roche
September 18, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 05, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio to Participate in Upcoming Investor Conferences
August 28, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Reports Second Quarter 2025 Financial Results and Corporate Updates
August 07, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 09, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 06, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
June 04, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 09, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio to Participate in Upcoming Investor Conferences
May 06, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Reports First Quarter 2025 Financial Results and Corporate Updates
May 01, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio to Participate in the Leerink Partners Global Healthcare Conference
March 03, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
February 27, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 06, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 03, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants
January 28, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
January 27, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Provides Business Update and Outlook for 2025
January 13, 2025
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 19, 2024
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 29, 2024
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio to Participate in the 7th Annual Evercore HealthCONx Conference
November 26, 2024
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024
November 15, 2024
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants
November 12, 2024
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
November 12, 2024
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Reports Third Quarter 2024 Financial Results and Corporate Updates
November 07, 2024
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio to Participate in the UBS Global Healthcare Conference
November 05, 2024
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting® 2024
October 15, 2024
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 11, 2024
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio to Participate in the H.C. Wainwright 8th Annual MASH Investor Conference
September 30, 2024
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 19, 2024
From
89bio, Inc.
Via
GlobeNewswire
Tickers
ETNB
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
